Levothyroxine Sodium is a drug marketed by Teva Pharms Usa Inc, Dr Reddys, Fresenius Kabi Usa, Maia Pharms Inc, Par Sterile Products, Piramal Critical, Custopharm Inc, Accord Hlthcare, Amneal, Lupin, Merck Kgaa, and Mylan and, and is included in fourteen NDAs. It is available from nineteen suppliers. There are five patents protecting this drug and two Paragraph IV challenges.
This drug has four patent family members in three countries.
The generic ingredient in LEVOTHYROXINE SODIUM is levothyroxine sodium. Nineteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the levothyroxine sodium profile page.
Copyright © DrugPatentWatch. Originally published at New patent for Fresenius Kabi drug LEVOTHYROXINE SODIUM